Antibodies to tumour necrosis factor α as treatment for Crohn's disease

被引：75

作者：

Bell, S ^{[1
]}

Kamm, MA ^{[1
]}

机构：

[1] St Marks Hosp, Dept Gastroenterol, Harrow HA1 3UJ, Middx, England

来源：

LANCET | 2000年 / 355卷 / 9207期

关键词：

D O I：

10.1016/S0140-6736(99)00442-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：858 / 860

页数：3

共 15 条

[1] Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications [J].

Baert, FJ ;

Rutgeerts, PR .

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1999, 14 (01) :47-51

[2] The relationship between infliximab treatment and lymphoma in Crohn's disease [J].

Bickston, SJ ;

Lichtenstein, GR ;

Arseneau, KO ;

Cohen, RB ;

Cominelli, F .

GASTROENTEROLOGY, 1999, 117 (06) :1433-1437

[3] LOWER GASTROINTESTINAL MALIGNANCY IN CROHNS-DISEASE [J].

CONNELL, WR ;

SHEFFIELD, JP ;

KAMM, MA ;

RITCHIE, JK ;

HAWLEY, PR ;

LENNARDJONES, JE .

GUT, 1994, 35 (03) :347-352

[4] LONG-TERM NEOPLASIA RISK AFTER AZATHIOPRINE TREATMENT IN INFLAMMATORY BOWEL-DISEASE [J].

CONNELL, WR ;

KAMM, MA ;

DICKSON, M ;

BALKWILL, AM ;

RITCHIE, JK ;

LENNARDJONES, JE .

LANCET, 1994, 343 (8908) :1249-1252

[5] BONE-MARROW TOXICITY CAUSED BY AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE - 27 YEARS OF EXPERIENCE [J].

CONNELL, WR ;

KAMM, MA ;

RITCHIE, JK ;

LENNARDJONES, JE .

GUT, 1993, 34 (08) :1081-1085

[6] Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].

D'Haens, G ;

Van Deventer, S ;

Van Hogezand, R ;

Chalmers, D ;

Kothe, C ;

Baert, F ;

Braakman, T ;

Schaible, T ;

Geboes, K ;

Rutgeerts, P .

GASTROENTEROLOGY, 1999, 116 (05) :1029-1034

[7] Therapeutic antibodies elicited by immunization against TNF-α [J].

Dalum, I ;

Butler, DM ;

Jensen, MR ;

Hindersson, P ;

Steinaa, L ;

Waterston, AM ;

Grell, SN ;

Feldmann, M ;

Elsner, HI ;

Mouritsen, S .

NATURE BIOTECHNOLOGY, 1999, 17 (07) :666-669

[8]

GREENSTEIN AJ, 1992, CANCER-AM CANCER SOC, V69, P1119

[9]

Hanauer SB, 1999, GASTROENTEROLOGY, V116, pA731

[10] Infliximab for the treatment of fistulas in patients with Crohn's disease [J].

Present, DH ;

Rutgeerts, P ;

Targan, S ;

Hanauer, SB ;

Mayer, L ;

van Hogezand, RA ;

Podolsky, DK ;

Sands, BE ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

van Deventer, SJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1398-1405

← 1 2 →